Zaldyon | Mesalamine Tablet, Delayed Release while Breastfeeding

What is Zaldyon | Mesalamine Tablet, Delayed Release used for?

I am currently breastfeeding and I want to know if using Zaldyon | Mesalamine Tablet, Delayed Release is safe for my kid? Does it have any effect on milk production?

Mesalamine while Breastfeeding

CAS Number: 89-57-6

Mesalazine is badly absorbed by the intestine, serum levels are low with scant excretion into breast milk. N-acetyl-5-ASA is an inactive metabolite which is excreted into breast milk but not higher than 10% of relative infant's dose. No harm effects among breastfed infants from treated mothers have been reported, except for rare cases of diarrhea reported in the 80's with the use of Mesalazine compounds different to Balsalazide. In a review of 121 cases and 121 controls, the authors failed to observe those findings. (Moretti, 1989). Expert consensus supports the compatibility of Mesalazine during breastfeeding.

Mesalamine while Breastfeeding

CAS Number: 89-57-6

Mesalamine is poorly excreted into breastmilk. However, rather high levels of the mesalamine metabolite N-acetyl-5-ASA appear in breastmilk and its effects on breastfed infants are unknown. A few cases of diarrhea have been reported in infants exposed to mesalamine, although the rate is not high. Most experts consider mesalamine derivatives to be safe during breastfeeding.[1][2][3][4] If mesalamine is required by the mother, it is not a reason to discontinue breastfeeding, but carefully observe breastfed infants for diarrhea during maternal use of mesalamine.

What if I already have used Zaldyon | Mesalamine Tablet, Delayed Release?

My health care provider has asked me to use Zaldyon | Mesalamine Tablet, Delayed Release, what to do?

If I am using Zaldyon | Mesalamine Tablet, Delayed Release, will my baby need extra monitoring?

Who can I talk to if I have questions about usage of Zaldyon | Mesalamine Tablet, Delayed Release in breastfeeding?